# OnCo record idea-cost-subcutaneous-community (idea). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/ideas/idea-cost-subcutaneous-community/>
  a schema:CreativeWork ;
  onco:kind "idea" ;
  schema:identifier "idea-cost-subcutaneous-community" ;
  schema:name "Give subcutaneous immunotherapy in community clinics and at home"@en ;
  schema:description "Under-the-skin versions of atezolizumab, nivolumab and pembrolizumab take minutes rather than an hour and need no infusion chair, so they can be given by a nurse near home, cutting facility fees and travel."@en ;
  schema:url <https://onco.cc/ideas/idea-cost-subcutaneous-community/> ;
  schema:dateModified "2026-09-10"^^xsd:date ;
  schema:citation <https://www.accessdata.fda.gov/scripts/cder/daf/> ;
  onco:sections <https://onco.cc/fronts/immunotherapy/> ;
  onco:technologies <https://onco.cc/technologies/checkpoint-inhibitor/> ;
  onco:drugs <https://onco.cc/drugs/atezolizumab/>, <https://onco.cc/drugs/nivolumab/>, <https://onco.cc/drugs/pembrolizumab/> ;
  onco:bottlenecks <https://onco.cc/bottlenecks/b-care-fragmentation/>, <https://onco.cc/bottlenecks/b-drug-pricing/>, <https://onco.cc/bottlenecks/b-workforce/>, <https://onco.cc/bottlenecks/b-global-access/> ;
  onco:keyPapers <https://onco.cc/key-papers/paper-checkmate-017-nejm-2015/>, <https://onco.cc/key-papers/paper-keynote-189-nejm-2018/>, <https://onco.cc/key-papers/paper-niche-2-nejm-2024/> .